breast cancer
Conditions
Interventions
Experimental group:1. Routine discharge guidance
2. Disease knowledge and skills manual
3. TTM based personalized guidance
4. Routine telephone follow-up in the first and third months
control group:1. Routine discharge guidance
2. Routine telephone follow-up in the first and third months
Sponsors
Cancer hospital of China Medical University, Liaoning Cancer Hospital & Institute
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. the pathological diagnosis of primary breast cancer, pathological stage II/III; 2. Estrogen receptor and/or progesterone receptor positive; 3. At least 18 years of age; 4. normal communication can accept the phone, family or wechat petition; 5. Voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: 1. participating in drug clinical trials; 2. With a history of other malignant tumors; 3. accompanied by other critical patients (such as serious infection, malignant hypertension, serious cerebrovascular accident, myocardial infarction, heart failure, etc.); 4. use of immune preparations; 5. change to chemoradiotherapy during endocrine treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| adherence; | — |
Secondary
| Measure | Time frame |
|---|---|
| health condition;Health knowledge awareness rate;health belief score;Health behavior score; | — |
Countries
China
Contacts
Public ContactXu Hui
Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute
Outcome results
None listed